Craig Douglas Schneider

Craig Douglas Schneider is a declared insider of InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,), with filings sourced from SEDI. In total, 13 filings cover trades dated from 9 June 2016 to 2 December 2016.

Both buying and selling appear: 1 purchase worth €2,114, against 9 sales worth €214k. The net balance comes to €212k on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 share grant. In 2017 alone, the filings show 1 purchase and 1 sale.

On 3 February 2017 came the latest disclosure, an open-market purchase for €2,114 in InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,). The median gap between a trade and its publication by SEDI is 16 days. The shorter that gap, the sooner other investors can see what insiders have done. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.